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ABSTRACT 
 
Background: bone replacement is frequently needed in periodontal, orthopaedic and 
maxillofacial diseases. To avoid complications with autografts and allografts, artificial grafts 
(scaffolds) are candidates for stimulating bone regeneration after colonization with osteoblasts. 
Moreover, osteoblast activity can be induced by biological or physical stimulation. In this research 
extracorporeal shock waves were used to improve the ability of human osteoblasts to colonise 
scaffolds and to induce their osteogenic properties. 
Methods: osteoblasts, treated with shock waves, were seeded on glass-ceramic macroporous 
scaffolds. Cells in scaffolds were counted after detachment, and examined for calcium nodule 
formation (Alizarin staining), for differentiation markers (real time PCR), and for scaffold 
colonization (scanning electron microscope). 
Results: shock waves initially increased both the number and the activity of osteoblasts in the 
scaffold, but subsequently only increased osteoblast activity. Moreover, shock waves favoured 
scaffold colonization even in the deeper layers. 
Conclusions: the calcium deposits and differentiation markers studied have demonstrated that shock 
waves increase osteoblast migration and penetration into scaffolds.  
Clinical relevance: this study may provide an important starting point for the introduction of shock 
waves to boost bone formation through osteoblast stimulation in diseases characterized by bone 
defects. 
 
KEYWORDS 
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INTRODUCTION 
 
Bone replacements are needed in cases of trauma, neoplasia, and in many periodontal diseases 
and orthopaedic and in maxillofacial surgery (1-3).  
At present, most injuries are not adequately treated because bone defects of critical size cannot be 
repaired by natural bone growth (4). Furthermore, due to the increase in mean population age and in 
surgery for removing tumors, bone regeneration is a clinical need of growing importance (5). 
Autografts, allografts or xenografts can be used as bone substitutes. The high degree of 
osteoinduction and osteogenesis obtained by autograft makes it the ideal choice. However, it 
presents some drawbacks, including scarce availability, the need for a second surgical operation and 
donor site morbidity (6-8). Allografts and xenografts, which can overcome these problems, are 
characterized by poorer bone induction, lower integration rate, a by no means negligible 
contamination risk, immune rejection and viral transmission (9,10). For these reasons, artificial 
grafts (scaffolds) are interesting and challenging candidates for stimulating bone regeneration and 
supporting newly formed bone (1-4,11). 
In previous work (12,13), 3D bioactive glass-ceramic scaffolds were successfully obtained by the 
sponge impregnation method using a polymeric template. These scaffolds, showing pores in the 
100-500 m range and trabecular morphology analogous to spongy bone, were highly bioactive as 
they induced the precipitation of hydroxyapatite on their surfaces. They were also osteoinductive, as 
evinced by osteoblast proliferation within the scaffold and synthesis of calcium nodules. Since these 
scaffolds are interesting candidates for bone tissue engineering applications, in this research human 
osteoblast-like cells were exposed to shock waves before seeding on the scaffold to increase their 
osteogenic activity. 
The adoption of shock waves to induce bone synthesis was prompted by several considerations. 
Extracorporeal shock waves were originally introduced in medical therapy to disintegrate calcific 
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deposits within renal, biliary and salivary tracts (14,15). More recently, shock waves have also been 
increasingly applied in various musculoskeletal disorders (16,17). 
Extracorporeal shock wave treatment has also been shown to increase the expression of bone 
morphogenetic protein (BMP)-2, -3, -4 and -7 in rats with femoral defects (18). 
In vitro studies on human osteoblast-like cells have shown that treatment with shock waves 
influence cell proliferation enhancing the transmembrane currents, as well as the voltage 
dependence of Ca-activated and K channels (19). 
Since at the moment little is known about the parameters regarding osteoblast activity induced 
by shock waves, in this study we have evaluated alkaline phosphatase (ALP), osteocalcin, type I 
collagen, BMP-4 and -7, as well as calcium deposits. 
 
MATERIALS AND METHODS 
 
Scaffold preparation 
Glass-ceramic macroporous scaffolds were obtained using an organic template (polyurethane 
sponge) and bioactive glass powders, as previously reported (12,13). The scaffolds (1 cm
3
) were 
soaked in Tris-buffered Simulated Body Fluid (SBF) before cell seeding to stimulate the 
precipitation of the hydroxyapatite layer, known to favour bone formation. 
Cell culture conditions 
Human osteoblast-like cell line, MG-63, (ATCC, Rockville, MD, USA) was grown in MEM 
medium containing 2 mM L-glutamine, 1% (v/v) antibiotic/antimycotic solution, 1 mM sodium 
pyruvate, and 10% (v/v) FBS (foetal bovine serum) in an atmosphere of 5% CO2 and 95% air at 37
o
 
C. 
Treatment of cells with shock waves 
The shock wave generator utilized was a piezoelectric device (Piezoson 100, Richard Wolf, 
Knittlingen, Germany) designed for clinical use in orthopaedics and traumatology. The instrument 
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generates focused underwater shock waves at various frequencies (1 to 4 impulses/sec) and 
intensities (0.05 to 1.48 mJ/mm
2
). For medical use, in orthopedics, shock waves of approximately 
0.01 to 0.6 mJ/mm
2
 are applied (20). 
The experimental set-up has been previously reported (21). Briefly, each cell-containing tube was 
placed vertically. The shock wave unit was kept in contact with the cell containing tube by means of 
a water-filled cushion. Common ultrasound gel was used as a contact medium between cushion and 
tube. 
MG-63 cells (10
6
/ml) were exposed to shock waves at different energy levels ranging from 0.08 to 
0.32 mJ/mm
2
. For each energy level, different numbers of impulses were tested (from 50 to 1000 at 
4 impulses/sec). MG-63 cells, exposed or not to shock waves, were seeded (10,000 cells/ cm
2
) in 
multiwells and used for counting cell numbers and analysing viability up to 10 days, to identify the 
shock wave exposure able to increase cell proliferation. After these preliminary experiments, only 
shock wave treatment corresponding to 0.22 mJ/mm
2 
and 100 total impulses was used (named E6 
100). 
Cell growth within scaffolds 
Sterilized scaffolds, pre-treated in SBF for 1 week, were preconditioned for 24 hours in multiwells 
containing culture medium. After removing preconditioning medium, MG-63 cells, treated with 
shock waves (0.22 mJ/mm
2 
and 100 total impulses) or not (control cells), were seeded (10,000 cells/ 
cm
2
) on the scaffolds. 
6, 10 and 20 days after cell seeding, the medium was removed and the scaffolds were used to count 
the cells that had grown within them, and to evaluate cell viability, morphology, presence of 
calcium deposits, and osteoblast activity parameters. With this aim, the scaffolds were treated with 
trypsin/EDTA (0.25%/0.3%) to harvest the cells present within them. 
Cell count and viability 
Cells were counted in a Burker chamber by using a light microscope (Leitz, Wetzlar, HM-LUX, 
Germany). To determine viability, plasmamembrane integrity was checked microscopically by 
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trypan blue exclusion test (dye concentration 0.8 mg/ml); 400 cells were counted for each sample 
and results were expressed as percentages of trypan blue-positive cells. 
Calcium deposit evaluation 
The determination of calcium deposits was carried out on cells grown within the scaffolds. After 
trypsinization, fixation in 70% ethanol and washing with Tris-Buffered Saline (TBS), cells were 
stained with 1% Alizarin red S for 2 min, washed with TBS and observed under light microscope 
(22). 
Morphology evaluation by scanning electron microscope (SEM) 
At the different experimental times, scaffolds not treated with trypsin (containing cells), scaffolds 
not containing cells (negative control) and scaffolds after treatment with trypsin to remove cells 
were rinsed four times in PBS and fixed with 2.5% glutaraldehyde in 0.1 M phosphate buffer (pH 
7.4) for 30 min at 4°C. Dehydration was performed with water replacement by a series of graded 
ethanol solutions with final dehydration in absolute ethanol. Cross sections of the scaffolds were 
then gold sputtered for SEM observation. 
Evaluation of osteoblast activity parameters by real-time PCR 
After 6 and 20 days cells detached from scaffolds were examined for osteoblast-activity parameters: 
ALP, osteocalcin, type I collagen, bone morphogenetic protein-4 and -7 (BMP-7, BMP-4). Total 
RNA was extracted using RNeasy Mini Kit® (QIAGEN, GmbH, Germany). 
Real-time PCR was performed using single-stranded cDNA prepared from total RNA (1 g) with 
the High Capacity cDNA Archive kit (Applied Biosystems, Foster City, CA, USA). Forward (FW) 
and reverse (RV) primers were designed using Beacon Designer software (Bio-Rad, Hercules, CA, 
USA) (Table 1). 
25 l of a PCR mixture, containing cDNA template equivalent to 80 ng of total RNA, 5 pmoles 
each of the forward and reverse primers and 2 iQ™ SYBR Green SuperMix (Bio-Rad, Hercules, 
CA, USA), were amplified using an iCycler PCR (Bio-Rad, Hercules, CA). Each sample of the 3 
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different experiments was tested 6 times and the threshold cycle (Ct) values were the corresponding 
mean. The fold change was defined as the relative expression compared to that at time 0 (time of 
seeding cells), calculated as 2
-∆∆Ct, where ∆Ct = Ctsample - CtGAPDH and ∆∆Ct = ∆Ctsample - ∆Cttime 0. 
Data are reported as variation percentages, calculated taking the values of control cells as 100.  
Statistical analysis 
All data were expressed as means  S.D. of  3 different experiments. The significance of differences 
between group means was assessed by variance analysis, followed by the Newman-Keuls test (p < 
0.05). 
 
 
RESULTS 
 
Human osteoblast-like cells MG-63 were treated with shock waves at different energy levels. 
For each energy level, the effect on cell proliferation of different numbers of impulses (ranging 
from 50 to 1000, 4 impulses/sec) was tested (data not shown). On the basis of these preliminary 
experiments the energy level, as well as the number of impulses required to stimulate cell 
proliferation were identified (0.22 mJ/mm
2 
per 100 impulses, named E6 100), and adopted in 
subsequent experiments. Immediately after shock wave exposure, this experimental condition 
caused a decrease in cell viability (-23%), then a significant increase in cell number, as shown in 
Figure 1 (panel A), and finally a tendential though not significant increase in the number of cell 
divisions (panel B). Increase in cell number reached the highest value 10 days after shock wave 
treatment. The variation percentage calculated for treated cells was 125%, taking the values of 
control cells as 100. Viability during all experimental times was the same for cells treated with 
shock waves and control cells, and remained about 100% (data not shown). The tendential increase 
in the numbers of new cells generated after treatment with shock waves, compared with those of the 
control cells, demonstrates the entity of increased colonization of the scaffold by osteoblasts as well 
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as their stimulating effect. Figure 1 also shows the total number of cells present within the scaffold 
at 6, 10 and 20 days after cell seeding (panel C). In shock wave-treated cells an increase in cell 
number was observed at 6 and 10 days after treatment, whereas a decrease was observed at 20 days. 
MG-63 cell spreading and migration within the scaffolds were evaluated by SEM analysis. 
Different cross-sections of the scaffolds were obtained (up to 5 mm from the surface) in order to 
compare the depth of colonization of the shock wave-treated cells with that of the control cells. In 
both cases MG-63 cells were observed to attach, spread, and proliferate to a greater degree at 10 
and 20 days than at 6 days. Moreover, SEM analysis showed that at 10 and 20 days, shock wave-
treated cells that penetrated to layers up to 5 mm deeper than control cells, which were only found 
on the surface. Figure 2 and Figure 3 report SEM micrographs of the surface and of the deepest 
layer (5 mm) of the scaffolds at 10 and 20 days, respectively. The cells colonising the scaffold 
strongly adhered to its porous structure and appeared to be closely attached to the surface. 
To determine the mineralization process, calcium deposits were shown up by staining the cells 
harvested from the scaffolds with Alizarin red S. Histochemical analysis (Figure 4) showed that 
after 10 days, a few Alizarin-positive areas had developed only in scaffolds colonised by shock 
wave-treated cells; at 20 days calcium deposits were observed in both control and shock wave-
treated cells, but they were more frequent and larger in scaffolds containing shock wave-treated 
cells. 
Markers of osteoblast activity were also examined. ALP, type I collagen, BMP-7, BMP-4 and 
osteocalcin mRNA was evaluated by real-time PCR at 6 and 20 days after shock wave exposure. 
Figure 5 shows that all the parameters examined were higher in shock wave-treated cells than in 
control cells, except for type I collagen at 6 days, BMP-7 and BMP-2 at 20 days, when the values 
were  120%, 90% and 53%, respectively, with control cell values taken as 100. The percentage 
values of increased gene expressions in treated cells were: at 6 days, 200% for ALP, 173% for 
osteocalcin, 283% for BMP-4, 152% for BMP-7 and 141% for BMP-2; at 20 days, 422% for ALP, 
312% for type I collagen, 207% for osteocalcin and 230% for BMP-4. 
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DISCUSSION 
Current opinion holds that significant improvements in bone regeneration will be obtained 
only by using new technologies based on tissue engineering supported by biochemical or 
biophysical stimulation. This science requires 3D-scaffolds able to mimic bone and to be colonised 
by osteoblast-like cells and their products. Among possible forms of biophysical stimulation, shock 
waves have recently been applied in a broad range of muscoloskeletal pathologies (16,17), even 
though some aspects of the mechanisms involved are still unclear. In this research it has been found 
that treating human osteoblast-like cells MG-63 with shock waves generated by a piezoelectric 
apparatus produces an increase in the number of osteoblasts and their degree of penetration into the 
scaffold. Regarding the increase in osteoblast number, the effect was different at various 
experimental times: at the earlier times (6 and 10 days after shock wave exposure) numbers of 
shock wave-treated cells present within the scaffold were higher than those of control cells, whereas 
at the last experimental time (20 days) the numbers were lower than in the controls. On the other 
hand, it has been shown that there were more and larger calcium deposits present in scaffolds 
colonized by shock wave-treated cells than those produced by control cells. In the light of these 
observations, we supposed that shock wave-treated cells at 20 days might proliferate less, but 
function more actively. To measure the parameters induced by shock waves resulting in an 
increased osteogenic activity of MG-63 cells, some markers have been studied. It has emerged that 
MG-63 cells exposed to shock waves expressed more ALP, osteocalcin, type I collagen, and all 
BMP-4, BMP-7 and BMP-2. ALP, type I collagen and osteocalcin showed the highest increase after 
20 days, whereas BMP-4, -7 and -2 after 6 days with a decrease after 20 days. It is known that ALP 
expression, which is an early marker of osteoblast differentiation, could be increased by BMP-4 
(23,24). 
BMPs enable skeletal tissue formation during embryogenesis, growth, adulthood, and healing. 
BMPs (BMP-2, -4, and -7) are the only growth and differentiation factors which can singly induce 
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de novo bone formation both in vitro and at heterotopic sites in vivo (25). Following a fracture, 
BMPs apparently diffuse from reabsorbing bone matrix and activate osteoprogenitor cells which, in 
turn, produce more BMPs. The temporal and spatial distribution of the BMPs during fracture 
healing has been moderately well characterized as a complex, interactive and site specific process 
(26,27,28). 
The observations described above suggest that shock waves initially induce an increase in  cell 
number and osteogenic activity, whereas induction of osteogenic activity prevails later. 
This research has shown that the use of physical stimulus, such as shock waves, induces osteoblast 
activity producing the same effect as using biological molecules, such as BMP-2, an osteoinductive 
growth factor able to determine osteoblast differentiation by increasing calcium deposits and 
accelerating the healing process when implanted in a bone defect. Our previous paper (12) 
described how in scaffolds colonised with human osteoblast-like cells treated with BMP-2, more 
and larger calcium deposits were produced than in the controls, suggesting that the higher degree of 
mineralization ability of the cells, though there was only a small number of them in the scaffold, 
was attributable to the BMP-2. In the same way, in SEM analysis, osteoblast-like cells were 
observed to attach, spread, proliferate and form mineralized nodules when cultured on bioactive 
scaffolds to a greater extent in BMP-2-treated cells than in controls (12). Therefore, shock waves 
treatment may be assumed to provide a good opportunity to stimulate osteoblast activity, preferable 
to the use of chemical substances. 
It should be noted that the importance of the use of shock waves lies in their ability to 
stimulate scaffold colonization and migration: since shock wave-treated cells have been found to 
penetrate further into scaffolds, whereas untreated cells remain on the surface. 
These encouraging results have led us to conclude that this study may well provide an 
important point of departure in the introduction of shock waves to enhance bone healing through 
osteoblast activity in bioactive glass-ceramic scaffolds. 
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Table 1 
Gene 
Access Number 
Sequence 
FW: forward primer;  RV: reverse primer 
Annealing 
(°C) 
Cycles 
GAPDH 
NM_002046 
FW-5’-GTC GGA GTC AAC GGA TTT GG-3’ 
RV-5’-GGG TGG AAT CAT ATT GGA ACA TG-3’ 
52 
 
30 
ALP 
NM_000478 
FW-5’-CTC CCA GTC TCA TCT CCT-3’ 
RV–5’-AAG ACC TCA ACT CCC CTG AA-3’ 
58 
 
40 
Osteocalcin 
NM_199173 
FW-5’-GTG ACG AGT TGG CTG ACC-3’ 
RV–5’-CAA GGG GAA GAG GAA AGA AGG-3’ 
59 
 
35 
Type I Collagen 
NM_000089 
FW-5’-ACA GCC GTC TCA CCT ACA GC-3’ 
RV–5’-GTT TTG TAT TCA ATC ACT GTC TTG CC-3’ 
60 
 
45 
BMP-7 
NM_001719 
FW-5’-GTG GAA CAT GAC AAG GAA T-3’ 
RV-5’-GAA AGA TCA AAC CGG AAC-3’ 
58 
 
40 
BMP-4 
D30751 
FW-5’-CTC GCT CTA TGT GGA CTT C-3’ 
RV-5’-ATG GTT GGT TGA GTT GAG G-3’ 
58 
 
45 
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Figure  
 
Figure 1 
Osteoblast proliferation after treatment with shock waves. 
Panel A: Numbers of osteoblast were counted after treatment with shock waves at the energy level 
of 0.22 mJ/mm
2 
and 100 impulses (E6 100) at the indicated experimental times. Data are means  
S.D. of 3 different experiments. 
Panel B: Numbers of cell divisions were counted as above described. 
Panel C: Numbers of osteoblasts, treated with shock waves (E6 100) and seeded on scaffols, were 
counted at the indicated experimental times after detachment from scaffold with trypsin. Data are 
means  S.D. of 3 different experiments. 
For each panel, means with different letters are significantly different from one another (p<0.05) as 
determined by analysis of variance followed by post-hoc Newman-Keuls test. 
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Figure 2 
Osteoblast spreading and migration onto the scaffolds evaluated by SEM analysis at 10 days. 
SEM micrographs of the surface and of deepest layer (5 mm) of the scaffolds show the osteoblasts 
treated (E6 100) or not treated with shock waves at 10 days after seeding on the scaffolds. 
 cells 
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Figure 3 
Osteoblast spreading and migration onto the scaffolds evaluated by SEM analysis at 20 days. 
SEM micrographs of the surface and of deepest layer (5 mm) of the scaffolds show the osteoblasts 
treated (E6 100) or not treated with shock waves at 20 days after seeding on the scaffolds. 
 cells 
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Figure 4  
Calcium deposits evidenced with Alizarin S staining 
Osteoblasts harvested from the scaffolds were stained with Alizarin red S and observed at light 
microscope. The cells treated (E6 100) or not treated with shock waves were harvested at 10 and 20 
days after seeding on the scaffolds. 
 calcium deposits 
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Figure 5 
Alkaline phosphatase (ALP), osteocalcin, type I collagen, bone morphogenetic protein-4, -7 and -2 
(BMP-4, BMP-7, BMP-2) mRNA content. 
mRNA content, at 6 and 20 days after seeding cells on scaffolds, was evaluated by real-time PCR 
and the values of osteoblasts treated with shock waves (E6 100) were referred to those of control 
cells taken as 100% (black line). 
Data are means  S.D. of 3 different experiments. For each panel, means with different letters are 
significantly different from one another (p<0.05) as determined by analysis of variance followed by 
post-hoc Newman-Keuls test. The control values are indicated as a. 
 
 
 
 
